MARKET

POAI

POAI

Predictive Oncology Inc
NASDAQ
1.330
-0.540
-28.88%
Opening 15:13 07/26 EDT
OPEN
1.470
PREV CLOSE
1.870
HIGH
1.545
LOW
1.210
VOLUME
5.56M
TURNOVER
0
52 WEEK HIGH
6.46
52 WEEK LOW
0.8940
MARKET CAP
5.46M
P/E (TTM)
-0.3634
1D
5D
1M
3M
1Y
5Y
1D
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Saia, Inc. Fell 18.6% to $398.01 on Friday. The company reported worse-than-expected second-quarter financial results. BurgerFi International and Windtree Therapeutics were among the stocks moving in today's mid-day session.
Benzinga · 8h ago
Predictive Oncology looks to raise $1.3M through exercise of warrants
Healthcare Predictive Oncology looks to raise $1.3M through exercise of warrants. Will exercise certain existing warrants to purchase 958.1K shares of its common stock. The warrants were originally issued in February 2021, June 2021 and May 2022. The gross proceeds from the exercise of the warrants are expected to be ~$1.26 million.
Seeking Alpha · 13h ago
Predictive Oncology Exercises Warrants For $1.26M Gross Proceeds
Predictive Oncology Inc. Is a leader in AI-driven drug discovery and biologics. The company has entered into a definitive agreement for the exercise of certain existing warrants to purchase shares of its common stock. The gross proceeds are expected to be approximately $1.26 million.
Benzinga · 13h ago
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
Predictive Oncology Inc. Is a leader in AI-driven drug discovery and biologics. The Company has entered into a definitive agreement for the exercise of certain warrants to purchase shares of its common stock. The gross proceeds from the exercise are expected to be approximately $1.26 million.
Barchart · 18h ago
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
POAI stock soared on the underlying massive total addressable market for biomarker discovery. Predictive Oncology's deep learning technology can more accurately forecast survival outcomes for ovarian cancer patients. The biotech firm has a market capitalization of $7.14 million. The global biomarker industry is expected to be worth $51.5 billion by year's end.
Investorplace · 1d ago
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Edwards Lifesciences Corporation shares dipped 26.9% to $63.60 on Thursday. The company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Predictive Oncology Inc. Shares jumped 85% after the company announced successful ovarian cancer study.
Benzinga · 1d ago
Why Predicitive Oncology Stock Is Soaring
Predictive Oncology Inc. Is expanding its AI and machine learning driven drug discovery platform to pursue discovery of novel biomarkers. The company's shares are blasting higher in pre-market trading. Predictive oncology says its latest initiative stems from ovarian cancer study.
Benzinga · 1d ago
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
U.S. Stocks traded higher midway through trading on Thursday. The Dow traded up 1.36% and the Nasdaq Composite gained over 1%. American Airlines Group Inc. Reported mixed second-quarter 2024 financial results and lowered its 2024 EPS outlook. Asian markets closed lower on Thursday; European markets were mixed. Predictive Oncology Inc. Shares shot up 67% after the company reported better-than-expected results.
Benzinga · 1d ago
More
About POAI
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.

Webull offers Predictive Oncology Inc stock information, including NASDAQ: POAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, POAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading POAI stock methods without spending real money on the virtual paper trading platform.